Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.
Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.
The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.
Publications found:
1,734
Sort by:
Europe Cancer Diagnostics Market 2021: Supplier Shares by Test and Country, Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK
US$ 19,700.00
... ; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding ...
August 2017
820 pages
Global Non-invasive Cancer Diagnosis Market Research and Forecast 2017-2022
US$ 3,600.00
... and molecular diagnosis holds the largest market share in the non-invasive cancer diagnosis market. Global Non-Invasive Cancer Diagnosis market is bifurcated as follows: Global Non-Invasive cancer diagnosis Market Research and Analysis, by Type Global Non-Invasive cancer diagnosis Market Research and Analysis ...
August 2017
-
United States Breast Cancer Screening Market Analysis: By Type, Share, Cases, Clinical Trials Insight, Reimbursement, Competitive Strategies and Forecast, 2017 - 2022
US$ 1,100.00
United States Breast Cancer Screening Market Analysis: By Type, Share, Cases, Clinical Trials Insight, Reimbursement, Competitive Strategies and Forecast, 2017 - 2022
August 2017
130 pages
Bladder Cancer [2017]
US$ 8,145.00
... to differentiate their marketed and pipeline therapies in KOL Insight: Bladder Cancer. Twelve US and European KOLs provide their candid insights on ... how do KOLs view Cyramza (ramucirumab) as a potential treatment for bladder cancer? What will be critical for commercial success in this indication? Which ...
July 2017
-
Breast Cancer [2017]: Bulletin #1
US$ 1,045.00
... events that have the potential to impact the treatment landscape of breast cancer (BC). Topics covered include expert opinions on: Roche announcing results from ...
July 2017
-
Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast – Worldwide
US$ 1,550.00
... . Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast – Worldwide is the 4th report published by Renub Research on Breast Cancer Screening Market. The report analyzes the Global market for Breast Cancer Mammography Screening Market, Breast Cancer MRI Screening Market and Breast Cancer ...
July 2017
-
Asia Breast Cancer Screening Market (Mammography, MRI & Ultrasound) Forecast
US$ 1,200.00
... market for breast cancer mammogram screening. Renub Research study titled “Asia Breast Cancer Screening Market (Mammography, MRI & Ultrasound) Forecast” analyzes the Asia market For Breast Cancer Mammography Screening Market, Breast Cancer MRI Screening Market and Breast Cancer Ultrasound Screening Market ...
July 2017
-
Colorectal Cancer [2016]: Bulletin #3
US$ 1,045.00
... presents key opinion leader (KOL) views on recent developments in the Colorectal Cancer (CRC) market. Topics covered include: Bristol-Myers Squibb (BMS ... mismatch repair deficient (dMMR) or microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC); Roche announcing data from two Phase I studies evaluating ...
July 2017
-
Prostate Cancer [2016]: Bulletin #3
US$ 1,045.00
... key opinion leader (KOL) insights on the latest events happening in prostate cancer.Topics covered include expert opinions on; the results of the Phase ... (cfDNA) can be used to assess treatment response in men with advanced prostate cancer who are administered with AstraZeneca's PARP inhibitor Lynparza (olaparib ...
June 2017
-
The Chinese Market for Cancer Intervention
US$ 5,500.00
The Chinese cancer intervention market reached nearly $41.1 billion in 2016. This market should reach $46.7 billion in 2017 and $89.3 billion by 2022, at a ... compound annual growth rate (CAGR) of 13.8% through 2022. Cancer treatment ...
June 2017
130 pages
Global Cancer Diagnostics Market Analysis 2021: USA, Europe, Japan--Supplier Shares and Strategies, Emerging Tumor Markers, Volume and Sales Segment Forecasts, Technology and Instrumentation
US$ 31,275.00
... the major business opportunities emerging in the global cancer diagnostics market during the ... market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers by country. Estimated universe of laboratories performing cancer diagnostic testing by country. Cancer ...
June 2017
1200 pages
Europe Breast Cancer Screening Market (Mammography, MRI & Ultrasound) Forecast to 2022
US$ 1,200.00
... . Europe Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast to 2022 is the 2nd Report published by Renub Research on Breast Cancer Screening Market. The report analyzes the Europe Breast Cancer Mammography Screening Market, Breast Cancer MRI Screening Market and Breast Cancer Ultrasound ...
June 2017
-
Global Dendritic Cell Cancer Vaccine Market & Clinical Trials Outlook 2023
US$ 2,000.00
... dendritic cell cancer vaccines in clinical pipeline. Most of the dendritic cell cancer vaccines are in preclinical phase followed by phase-II clinical trials. “Global Dendritic Cell Cancer Vaccine Market & Clinical Trials Outlook 2023” Highlights: Global Dendritic Cell Cancer Vaccine ...
June 2017
170 pages
Prostate Cancer Therapeutics - Global Market Outlook (2017-2023)
US$ 4,150.00
... Prostate Cancer Therapeutics market is estimated at $XX million in 2016 and is expected to reach $XX million by 2023 growing at a CAGR of XX% from 2016 to 2023. Increase in prostate cancer ... period because of government initiatives on creating awareness on prostate cancer. Some of the key players in the market ...
May 2017
148 pages
Global Ovarian Cancer Drugs Market Research and Analysis, 2015-2022
US$ 3,495.00
... most common ovarian cancer type. 1. Global Ovarian Cancer Drugs Market Research And Analysis, By Cancer Type 1.1. Epithelial Ovarian Tumors 1.2. Ovarian Germ Cell Tumors 1.3. Ovarian Stromal Tumors 1.4. Primary Peritoneal Carcinoma 2. Global Ovarian Cancer Drugs Market Research ...
May 2017
-
Global Cancer Biomarkers Market Analysis & Forecast Report 2017
US$ 2,600.00
The Global Cancer Biomarkers Market Analysis & Forecast Report 2017 is a professional and in-depth study on the current state of the Cancer Biomarkers Market. The report analysis the global market of Cancer Biomarkers by main manufactures and geographic regions. The report includes Cancer Biomarkers definitions, classifications, applications and ...
May 2017
95 pages
Global Endometrial Cancer Therapeutics Market By Therapy (Chemotherapy, Hormone Therapy, Radiation Therapy, Surgery), By Enduser (Research Institutes, Hospitals & Clinics), & Pipeline Analysis, Outlook to 2023
US$ 2,500.00
... I or II endometrial cancer. Radiation Therapy is also recommended in patients who have undergone the surgery to avoid the relapse of endometrial cancer. According to the RNCOS report entitled “Global Endometrial Cancer Therapeutics Market By Therapy (Chemotherapy, Hormone Therapy, Radiation Therapy, Surgery), By Enduser (Research Institutes, Hospitals & Clinics), & Pipeline Analysis, Outlook to 2023”, the Endometrial Cancer therapeutics market is poised ...
May 2017
100 pages
Ovarian Cancer [2017]
US$ 8,145.00
... an alternative to chemotherapy in the treatment of relapsed BRCA-mutated high-grade ovarian cancer? How will recently approved Zejula compete with the existing ... term outlook for Avastin in ovarian cancer? How do KOLs view the combination of cediranib with Lynparza as a treatment for recurrent ovarian cancer? Quotes “Some of these ...
May 2017
-
North America Prostate Cancer Diagnostics Market by Manufacturers, Countries, Type and Application, Forecast to 2022
US$ 4,480.00
... exam, biopsy and others to diagnostic whether patients with breast cancer. SCOPE OF THE REPORT: This report focuses on the Prostate Cancer Diagnostics in North America market, especially in United ... into < 55 55-75 > 75 There are 15 Chapters to deeply display the North America Prostate Cancer Diagnostics market. Chapter 1, to describe Prostate Cancer Diagnostics Introduction, product type and application, market overview, market ...
April 2017
119 pages
Global Breast Cancer Predictive Genetic Testing Market Outlook 2022
US$ 2,000.00
... Breast Cancer Predictive Genetic Testing Market Outlook 2022” Report Highlights: Hereditary Breast Cancer Genes Conceptual of Breast Cancer Susceptibility Predictive Cancer Testing Essentials Economical, Ethical & Social Aspects Global Prevalence of Breast Cancer Market & Cost Analysis of Predictive Testing ...
April 2017
140 pages
Cancer Diagnostics 2021: Supplier Shares and Strategies, Country Segment Forecasts, Tehnology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 31,275.00
... Current and Emerging Cancer Diagnostic Test Oncogenes Biochemical Markers Growth Factors Colony Stimulating Factors Hormones Immunohistochemical Stains Lymphokines Supplier Shares, Sales and Volume Forecasts Sales and market shares of major cancer diagnostic product suppliers by individual test and country ...
March 2017
1200 pages
2017 Spain Hospital Hematology and Flow Cytometry Markets
US$ 3,465.00
... a comprehensive analysis of the Spanish hospital hematology and flow cytometry markets, including: Major issues pertaining to the Spanish hematology and flow cytometry practice ... major hematology and flow cytometry tests performed in Spanish hospitals. Annual placements and installed base estimates for major automated and semiautomated hematology ...
March 2017
236 pages
2017 Germany Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Instrument and Reagent Supplier Shares, Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies
US$ 5,490.00
... explores future marketing and technological trends in the Germany; provides estimates of the test volume, instrument placements ... ten years.Blood Typing and Grouping TestsABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, ...
March 2017
426 pages
2017 Japan Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Instrument and Reagent Supplier Shares, Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies
US$ 6,930.00
... report explores future marketing and technological trends in the Japan; provides estimates of the test volume, instrument placements ... ten years.Blood Typing and Grouping TestsABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, ...
March 2017
426 pages
2017 Europe Coagulation Reagent and Instrument Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK
US$ 17,730.00
... and consumable suppliers during the next five years. Coagulation Tests Activated Clotting Time (ACT) (1), Activated Protein C Resistance, ... and operating characteristics. Alternative market penetrationstrategies for instrument and reagent suppliers. Potential market entry barriers and risks. Contains ...
March 2017
500 pages
2017 Australia Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...
March 2017
535 pages
2017 Austria Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...
March 2017
535 pages
2017 Belgium Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...
March 2017
535 pages
